Shinichiro Ueda

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Cardiovascular Risk Factors

Top Venues

Cardiovascular drugs and therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa, Nobukazu Ishizaka, Yumiko Kanzaki, Hirofumi Tomiyama, Masataka Sata, Akira Sezai, Kazuo Eguchi, Toru Kato, Shigeru Toyoda, Ryoichi Ishibashi, Kazuomi Kario, Tomoko Ishizu, Shinichiro Ueda, Koji Maemura, Yukihito Higashi, Hirotsugu Yamada, Mitsuru Ohishi, Kotaro Yokote, Toyoaki Murohara, Jun-Ichi Oyama, Koichi Node, null null
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial. PLoS medicine 17 (4) (2020)
Susumu Shinoura, Akihiro Tokushige, Kenji Chinen, Hideki Mori, Shin Kato, Shinichiro Ueda
Endosonographic finding of the simultaneous depiction of bile and pancreatic ducts can predict difficult biliary cannulation on endoscopic retrograde cholangiopancreatography. PloS one 15 (7) (2020)
Shinichiro Ueda, Michio Shimabukuro, Osamu Arasaki, Koichi Node, Takashi Nomiyama, Takeshi Morimoto
Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial. Cardiovascular drugs and therapy 32 (1) (2019)
Hiroyuki Hirai, Moritake Higa, Takeshi Morimoto, Mio Sakuma, Osamu Arasaki, Takashi Nomiyama, Koichi Node, Shinichiro Ueda, Michio Shimabukuro
Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial. Journal of clinical medicine 9 (1) (2019)